New Study Finds Danger In Standard Treatment For Lung Disease
A new study conducted inpart by a University of Michigan lung specialists finds that a combination of three drugs used worldwide as the standard of care for a serious lung disease puts patients in danger of death or hospitalization, and should not be used together to treat the disease, called idiopathic pulmonary fibrosis.
